Intelligence / Healthtech / Health Funding Register / Can-Fite BioPharma Ltd.
Fundingraised $8.3M10 Sept 2026
Can-Fite BioPharma Ltd.
10 Sept 2026: Raised $8.3M · Ramat Gan, L3. Recorded in the SEC Form D data sets.
- Filed
- 10 Sept 2026
- Location
- Ramat Gan, L3
- State
- Israel
- Industry
- Pharmaceuticals
- Amount raised
- $8.3M
- Offering size
- $8.3M
- Revenue range
- Decline to Disclose
- Entity type
- Corporation
- Jurisdiction
- Israel
- First sale
- 2026-09-02
- Securities
- Equity, Options
- Investors so far
- 1
- SEC CIK
- 0001536196
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Can-Fite BioPharma Ltd.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Israel
Health Funding Register
10 SeptPolyrizon Ltd.raised $4.0M · Raanana, L3Funding9 SeptBioLineRx Ltd.raised $3.8M · Modi'In, L3Funding4 SeptPluri Inc.raised $3.7M · Haifa, L3Funding21 AugNurExone Biologic Inc.raised $450K · Technion City, Haifa, L3Funding19 AugIntercure Ltd.filed a raise · Hertzliya, L3Funding12 AugEntera Bio Ltd.raised $275M · Jerusalem, L3Funding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.